The Role of Intermittent Fasting in Parkinson's Disease
Authors:
Open Access
- 1 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12
Abstract
The Role of Intermittent Fasting in Parkinson's DiseaseKeywords
This publication has 48 references indexed in Scilit:
- Exenatide and the treatment of patients with Parkinson’s diseaseJournal of Clinical Investigation, 2013
- Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astrogliaGlia, 2012
- Alpha‐synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson’s diseaseJournal of Neurochemistry, 2012
- PINK1- and Parkin-mediated mitophagy at a glanceJournal of Cell Science, 2012
- LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1Human Molecular Genetics, 2012
- Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial AutophagyJournal of Biological Chemistry, 2011
- In vivo demonstration that α-synuclein oligomers are toxicProceedings of the National Academy of Sciences, 2011
- Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's diseaseParkinsonism & Related Disorders, 2009
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- An Energy Budget for Signaling in the Grey Matter of the BrainJournal of Cerebral Blood Flow & Metabolism, 2001